Correlation Between Lipum AB and Simris Alg
Specify exactly 2 symbols:
By analyzing existing cross correlation between Lipum AB and Simris Alg AB, you can compare the effects of market volatilities on Lipum AB and Simris Alg and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipum AB with a short position of Simris Alg. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipum AB and Simris Alg.
Diversification Opportunities for Lipum AB and Simris Alg
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipum and Simris is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Lipum AB and Simris Alg AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simris Alg AB and Lipum AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipum AB are associated (or correlated) with Simris Alg. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simris Alg AB has no effect on the direction of Lipum AB i.e., Lipum AB and Simris Alg go up and down completely randomly.
Pair Corralation between Lipum AB and Simris Alg
Assuming the 90 days trading horizon Lipum AB is expected to generate 0.64 times more return on investment than Simris Alg. However, Lipum AB is 1.56 times less risky than Simris Alg. It trades about 0.04 of its potential returns per unit of risk. Simris Alg AB is currently generating about -0.01 per unit of risk. If you would invest 1,065 in Lipum AB on December 2, 2024 and sell it today you would earn a total of 615.00 from holding Lipum AB or generate 57.75% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lipum AB vs. Simris Alg AB
Performance |
Timeline |
Lipum AB |
Simris Alg AB |
Lipum AB and Simris Alg Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipum AB and Simris Alg
The main advantage of trading using opposite Lipum AB and Simris Alg positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipum AB position performs unexpectedly, Simris Alg can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simris Alg will offset losses from the drop in Simris Alg's long position.Lipum AB vs. Ascelia Pharma AB | Lipum AB vs. NextCell Pharma AB | Lipum AB vs. Annexin Pharmaceuticals AB | Lipum AB vs. AlzeCure Pharma |
Simris Alg vs. SenzaGen AB | Simris Alg vs. AAK AB | Simris Alg vs. Scibase AB | Simris Alg vs. Scandinavian Enviro Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |